Browse Event Schedules by Type:
Featured
When It Could Be Cystic Fibrosis (CF): Diagnosing CF in People with Atypical Disease Presentation
Innovation Theater 1
Sponsored by Vertex Pharmaceuticals, Inc.
Clinical and patient-centered discussions on the role of inflammation in bronchiectasis
Innovation Theater 5
Sponsored by Insmed
Elevating Asthma Control: Implications for Your Pediatric Patients
Innovation Hub 1
Sponsored by sanofi | regeneron
Pulmonary Alveolar Proteinosis: Pathophysiology, Diagnosis, and Management
Innovation Theater 4
Sponsored by Savara Inc.
Tools of the Trade: Imaging in ILD
Innovation Hub 3
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
Asthma Drivers of Disease: the effects of IL-5 on eosinophils and other cell types that contribute to airway remodeling and disease progression.
Innovation Theater 1
Sponsored by GSK
Interstitial Lung Disease: Presentation to Patient Experience
Innovation Theater 5
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
Earlier Assessment of Uncontrolled Moderate-to-Severe Asthma. Is There More We Can Do?
Innovation Hub 2
Sponsored by sanofi | regeneron
Understanding the Pathophysiology and Burden of COPD With Blood Eosinophils as a Marker of T2 Inflammation – Is it the Time for Precision Medicine in COPD?
Innovation Theater 3
Sponsored by GSK
Clinical Considerations for Sleep Specialists on the Improvement of Wakefulness in Patients With Excessive Daytime Sleepiness
Innovation Theater 5
Sponsored by Axsome Therapeutics, Inc.
Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?
Manchester Grand Hyatt – Seaport Ballroom FGH
Sponsored by sanofi | regeneron
Exploring the Impact of OFEV® (nintedanib) capsules
Marriott Marquis – Marina Ballroom F/G
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
Expectations for Oral Corticosteroid Use
Innovation Theater 3
Sponsored by sanofi | regeneron
Holistic Care of the Immunocompromised Pulmonary Patient with EGPA
Innovation Theater 2
Sponsored by GSK